ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!Mangoceuticals, Inc. (MGRX) stock declined over -321.78%, trading at $3.91 on NASDAQ, down from the previous close of $4.04. The stock opened at $4.00, fluctuating between $3.89 and $4.01 in the recent session.
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Employees | 3 |
Beta | 1.51 |
Sales or Revenue | $731.49K |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Healthcare Information Services |
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com